x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

Global Regions ( XML Feed )
United States ( XML Feed )

Dec 23, 2015 11:13 EST

RJSBiologics: strives to better serve cancer patients

iCrowdNewswire - Dec 23, 2015

RJSBiologics

RJSBiologics Logo

RJSBio strives to better serve cancer patients by providing promising new targeted drugs that may help make their cancer treatments more predictable. Please contact [email protected]

We focus on removing known liabilities from cancer drugs associated with off-target effects. We have developed a novel drug conjugate approach that uses computationally designed affinity tags to drive therapeutic compounds into cancer cells. This novel targeted approach is anticipated to improve the predictability of cancer drug development.

Our affinity tags facilitate effective tumor cell uptake of conjugated drugs by allowing drugs to be ferried into cancer cells using cancer proteins. Our design minimizes unwanted uptake of these drugs by normal cells, where harmful side effects are manifested. RJS Biologics’ innovative approach should be broadly applicable to many cancer drugs.

Products / Services

BioPharmaceuticals Sectors: Oncology and Anti-Inflammatory

We have developed a novel drug conjugate approach that uses computationally designed affinity tags to drive therapeutic compounds into cancer cells. This novel targeted approach is anticipated to improve the predictability of cancer drug development. Our affinity tags facilitate effective tumor cell uptake of conjugated drugs by allowing drugs to be ferried into cancer cells using cancer proteins. We strive to minimize unwanted uptake of these drugs by normal cells. RJS Biologics’ innovative approach should be broadly applicable to many cancer drugs.

Contact Information:

Stephen McCraith

View Related News >
support